経口吸収を介した薬物相互作用に対応するPBPKモデリング
Xinyuan Zhang1, Grace Fraczkiewicz1, Viera Lukacova1
1Simulations Plus, Inc., P.O. Box 12317, Research Triangle Park, NC, 27709, USA.
Drug metabolism and pharmacokinetics
|February 8, 2026
まとめ
生理学的薬物動態(PBPK)モデリングは、胃のpHや食事などの相互作用によって薬物吸収がどのように影響されるかを予測するのに役立ちます。このアプローチは、開発中の薬物の安全性と有効性を評価するのに役立ちます。
科学分野:
- 薬物動態学と薬物代謝;薬物相互作用と安全性;薬理学における計算モデリング
背景:
- 薬物吸収は、薬物動態(PK)およびADME(吸収、分布、代謝、排泄)の重要な要因です。吸収中の薬物間相互作用(DDI)は、薬物のPKを大きく変化させ、安全性と有効性に影響を与える可能性があります。生理学的薬物動態(PBPK)モデリングは、これらの吸収を介したDDIを評価するための貴重なツールです。
研究 の 目的:
- 胃腸の要因に焦点を当て、経口吸収を介したDDIの主要なメカニズムをレビューすること。PBPKモデリングを吸収を介したDDIの予測と評価に適用すること。DDI評価におけるPBPKモデリングの規制上の受け入れと将来の方向性について議論すること。
主な方法:
- 薬物相互作用に及ぼす経口吸収メカニズムに関する文献レビュー。胃のpH、胃排出、胃腸通過、食事の影響に関連するDDIのシミュレーションと予測のためのPBPKモデリングの適用。FDAおよびEMAなどの規制当局からのケーススタディと規制ガイドラインの分析。
主要な成果:
- PBPKモデリングは、胃のpH、胃内通過時間、食事の影響の変化に起因するDDIを効果的に予測します。ケーススタディは、吸収を介したDDIリスクの評価におけるPBPKの有用性を実証しています。規制当局は、PBPKベースのDDI評価をますます受け入れています。
結論:
- PBPKモデリングは、吸収を介したDDIリスクを評価するためのメカニズム的アプローチを提供し、薬物開発をサポートします。胃腸の要因に焦点を当てることは、薬物吸収のばらつきに関する貴重な洞察を提供します。機械学習との将来の統合とグローバルな規制調和は、PBPKアプリケーションをさらに強化するでしょう。
関連する概念動画
Non-Oral Extravascular Drug Absorption Routes
539
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
539
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
6.2K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
6.2K
Drug Absorption: Factors Affecting GI Absorption
6.3K
The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
6.3K
Drug Absorption: Overview
1.9K
The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
1.9K
Factors Influencing Drug Absorption: Drug Dissolution
1.2K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.2K
Pharmacokinetics: Drug–Drug Interactions
455
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
455


